Editorial note: This article is educational and independent
Contact Us IGF-1 LR3 (Long Arg3-IGF-1) is a synthetic 83-amino-acid analogue of insulin-like growth factor 1, engineered with an N-terminal 13-amino-acid extension and an Arg3 substitution that together confer markedly reduced affinity for IGF-binding proteins (IGFBPs) and extended plasma half-life
It is designed for controlled laboratory investigation of GH/IGF-1 signaling pathways, combining sustained GHRH receptor engagement from CJC-1295 with pulsatile ghrelin receptor activation from Ipamorelin
SURMOUNT-MMO, an event-driven cardiovascular efficacy trial evaluating tirzepatide in adults with obesity, is expected to be completed in October 2027 (NCT05556512)
GHK-Cu activates fibroblasts, the cells responsible for collagen and elastin synthesis, and triggers extracellular matrix remodeling through metalloproteinase regulation
Vitamin D and its therapeutic relevance in pulmonary diseases
